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Background. Parallel upregulation of several T-cell effector functions (ie, polyfunctionality) is believed to be critical for the pro-
tection against viruses but thought to decrease in large T-cell expansions, in particular at older ages. The factors determining T-cell
polyfunctionality are incompletely understood. Here we revisit the question of cytomegalovirus (CMV)–speciﬁc T-cell polyfunction-
ality, including a wide range of T-cell target proteins, response sizes, and participant ages.
Methods. Polychromatic ﬂow cytometry was used to analyze the functional diversity (ie, CD107, CD154, interleukin 2, tumor
necrosis factor, and interferon γ expression) of CD4+ and CD8+ T-cell responses to 19 CMV proteins in a large group of young and
older United Kingdom participants. A group of oldest old people (age >85 years) was included to explore these parameters in ex-
ceptional survivors. Polyfunctionality was assessed for each protein-speciﬁc response subset, by subset and in aggregate, across all
proteins by using the novel polyfunctionality index.
Results. Polyfunctionality was not reduced in healthy older people as compared to young people. However, it was signiﬁcantly
related to target protein speciﬁcity. For each protein, it increased with response size. In the oldest old group, overall T-cell polyfunc-
tionality was signiﬁcantly lower.
Discussion. Our results give a new perspective on T-cell polyfunctionality and raise the question of whether maintaining poly-
functionality of CMV-speciﬁc T cells at older ages is necessarily beneﬁcial.
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The numbers of fresh, naive cells leaving the thymus declines
early in life. However, T-cell numbers are maintained at a cons-
tant level in adults [1] because memory T cells proliferate to
compensate for this shortfall. Cytomegalovirus (CMV) appears
to be a uniquely effective driver of this compensatory prolifer-
ation, sometimes producing very large T-cell expansions [2, 3].
It is unclear how these changes affect the functional diversity
(ie, polyfunctionality) of T cells. Polyfunctionality is an impor-
tant T-cell quality, which has been linked to protection in cer-
tain vaccine models [4–7]. Several studies have explored T-cell
polyfunctionality at older ages, but it is not known whether this
varies with respect to the CMV protein target and/or response
size. Previous work on CMV-related T-cell polyfunctionality
has focused on just 1 or 2 frequently recognized, reportedly
dominant CMV proteins [8, 9], but it is unlikely that the poly-
functionality of 1 or 2 dominant responses sufﬁciently captures
the overall polyfunctionality of the T-cell response (including
dominant and subdominant responses) to this pathogen [10].
We therefore decided to revisit this interesting question, taking
into account a wider, more representative range of CMV target
proteins than previously studied. By analyzing 5 functional
readouts for CD4+ and CD8+ T-cell responses to the 19 most
representative CMV target proteins [11] in young and older
people, we explored whether polyfunctionality is fully preserved
in older people and how this is linked to target protein speciﬁc-
ity and response size.
METHODS
Ethics Statement
This study was approved by the United Kingdom National Re-
search Ethics Service (09/H1102/84). Written informed consent
was obtained from all participants. The study was conducted in
agreement with the Declaration of Helsinki.
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Blood Donors
As part of a larger study, CMV-speciﬁc T-cell responsiveness was
examined in CMV-infected (ie, IgG-seropositive) young (19–35
years old) and older (60–85 years old) individuals in East Sussex,
United Kingdom. Healthy young volunteers included university
students/staff; healthy older volunteers were recruited through
general practitioners afﬁliated to the United Kingdom National
Institute of Health Research Primary Care ResearchNetwork. Ex-
clusion criteria were known immunodeﬁciency (including
human immunodeﬁciency virus infection), organ transplanta-
tion, use of immunosuppressive or immunomodulating drugs
within the last year (excluding acetylsalicylic acid ≤100 mg/
day), current neoplastic disease or treatment for cancer within
the previous 5 years, insulin-dependent diabetes, moderate or ad-
vanced renal failure, liver disease, endocrine disorders (except
corrected thyroid dysfunction), autoimmune disease, dementia/
mental incapacity, alcohol/other drug abuse, acute infection or
illness in the last 4 weeks, and raised body temperature (>37.5°C).
An additional 22 CMV-positive individuals with previously
known T-cell responsiveness to CMV were recruited in Parma,
Italy, as a comparison group of individuals of particularly ad-
vanced age (85–102 years; hereafter referred to as “oldest old”).
Inclusion criteria for Italian volunteers were minimum age of
85 years and known CMV responsiveness; exclusion criteria
were evidence of endocrine disorders (except thyroid dysfunc-
tion), autoimmune and neoplastic diseases, acute infections or ill-
ness in the last 2 months, renal or liver failure, and use of
immunomodulatory medications (including steroids, nonsteroi-
dal antiinﬂammatory agents, acetylsalicylic acid >100 mg/day, or
immunosuppressive drugs). Individuals with cerebrovascular
and/or cardiovascular disease were accepted, as the goal was to
include individuals representative of such an advanced age co-
hort. Demographic characteristics are shown in Table 1.
CMV Status
CMV serological analysis (by use of the Architect CMV IgG
assay, Abbot, Maidenhead, United Kingdom) was performed
in the Brighton and Sussex University Hospital Trust virology
laboratory.
Peripheral Blood Mononuclear Cell (PBMC) Isolation and Activation
PBMCs were isolated from fresh, sodium heparin-anticoagulated
venous blood by density gradient centrifugation (Ficoll-Hypaque,
PLUS Healthcare, Buckinghamshire, United Kingdom) [12].
PBMCs were resuspended at 5 × 106 cells/mL in complete Ros-
well Park Memorial Institute medium (Fisher Scientiﬁc, Lough-
borough, United Kingdom) containing 10% fetal calf serum
(Fisher). Twenty-ﬁve micrograms per peptide of CMV peptide
pools (PepMix; JPT Peptide Technologies, Berlin, Germany)
was dissolved in 100 µL of dimethyl sulfoxide (DMSO;
Sigma-Aldrich, Gillingham, United Kingdom). A total of 2 µL
of peptide solution, 1.5 µL of anti-CD107a (BD), and 0.5 µL of
Monensin (BD) were added to 56 µL of complete medium and
placed in 4.5-mL polystyrene tubes (BD). Then 200 µL of
PBMC suspension was added, and tubes were incubated at
37°C in a standard incubator in a humidiﬁed 5% CO2 atmo-
sphere. Brefeldin A (5 µg/mL; Sigma) was added after 2
hours, and samples were incubated for additional 14 hours.
Final concentrations of peptide were 1 µg/mL per peptide for
each pool. Staphylococcus enterotoxin B (Sigma) was dissolved
in DMSO and used at 1 µg/mL (ﬁnal concentration) as a posi-
tive stimulation control; peptide solvent (DMSO) alone served
as a negative control. At the end of the incubation time, 100 µL
of a 20 mM ethylenediaminetetraacetic acid (EDTA) buffer was
added to each tube and incubation continued for 10 minutes at
37°C. EDTA buffer was freshly prepared by adding Na EDTA
(Sigma) to wash buffer consisting of phosphate-buffered saline
(PBS) supplemented with 0.5% bovine serum albumin and 0.1%
sodium azide (Sigma). Tubes were vortexed and then incubated
for a further 10 minutes at 37°C. After spinning at 400×g for 8
minutes at 4°C, pellets were washed once more with wash buffer
(same centrifuge settings) and then resuspended for staining.
CMV Peptide Pools
Peptides (15 amino acids long, with 11 overlaps between adja-
cent peptides) covering the amino acid sequences for CMV pro-
teins UL28, UL32, UL36, UL48, UL55, UL82, UL83, UL86,
UL94, UL99, UL103, UL122, UL123, UL151, UL153, US3,
US24, US29, and US32 were prepared by solid-phase synthesis
[11, 13]. All peptides were quality controlled by mass spectro-
scopy and high-performance liquid chromatography. Peptide
purity was >80%. One single pool was generated for each pro-
tein, except for the largest protein, UL48, for which 2 pools were
generated (Pepmix; JPT Peptide Technologies, Berlin, Germa-
ny). Freeze-dried pools were stored at −80°C. The 19 original
CMV peptide pools were arranged in 16 stimulation pools, of
which 12 pools contained just 1 protein (expected to elicit fre-
quent responses) and 4 pools contained 2 proteins each (expect-
ed to elicit less frequent responses; Table 2).
Table 1. Demographic Characteristics of Cytomegalovirus-Positive
Participants in the United Kingdom and Italy, by Age Group
Parameter
Young, United
Kingdom (n = 26)
Older, United
Kingdom (n = 69)
Oldest Old,
Italy (n = 22)
Age, y
Range 19–35 60–85 85–103
Mean ± SD 23.3 ± 4.2 69.0 ± 7.5 95.9 ± 5.9
Female sex 18 (69) 35 (51) 16 (73)
Male sex 8 (31) 34 (49) 6 (27)
White (British or
Italian)
18 (69) 69 (100) 22 (100)
Nonwhite
Britisha
8 (31) 0 (0) 0 (0)
Data are no. (%) of participants, unless otherwise indicated.
a Included 1 Syrian, 2 Indian, 1 Sri Lankan, 1 Bangladeshi, 1 Malaysian, 1 White/Asian, and 1
Black African/Asian participants.
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Antibodies
We used the following ﬂuorescence-conjugated monoclonal an-
tibodies and staining reagents: anti-CD3-v500, anti-CD8-allo-
phyocyanine (APC)-H7, anti-CD27-phycoerythrine (PE),
interleukin 2 (IL-2)-ﬂuorescein isothiocyanate (FITC), tumor
necrosis factor α (TNF-α)-Alexa 700, and CD107a-APC (all
BD Biosciences, Oxford, United Kingdom); anti-CD4-peridinin
chlorophyll (PerCP), anti-interferon γ (IFN-γ) PE-cyanine 7,
anti-CD154 Paciﬁc-Blue (BioLegend, Cambridge, United King-
dom), anti-CD45RA-ECD (Beckman Coulter, United King-
dom), and Yellow live-dead stain (Invitrogen, Paisley, United
Kingdom).
Intracellular Cytokine Staining
Staining antibodies were added, and tubes were incubated for 30
minutes at 4°C. After a further wash, red blood cells were lysed
with FACS Lysing solution (BD) and then permeabilized with
BD Permeabilizing solution 2 (BD) according to the manufac-
turer’s instructions. Cells were then stained intracellularly fol-
lowing the same steps as used for surface staining. Following
a ﬁnal wash, pellets were resuspended and ﬁxed in PBS contain-
ing 0.5% paraformaldehyde (Sigma) prior to acquisition on an
LSRII ﬂow cytometer, using FACSdiva 6.1 software (BD).
Data Analysis and Gating Strategy
After stimulation, activated cells were enumerated by ﬂow cy-
tometry, using 5 simultaneous T-cell activation readouts:
CD107, CD154, IL-2, TNF, and IFN-γ. Data analysis was per-
formed with FlowJo-v9.x software (TreeStar, Ashland, OR). De-
tails of the gating strategy are available in Supplementary
Figure 1. Individual gates were set on activation-marker-
positive CD4+ and CD8+ T cells. For each subset these were
combined using the Boolean gate function in FlowJo, generating
32 subsets each (31 functional subsets and 1 without any of the
tested functions). Net subset frequencies were determined by
background subtraction (subset by subset). Responses were con-
sidered negative if they were not identiﬁable by at least 1 activa-
tion marker and a visible cell cluster exceeding 1/10 000 CD4+
or CD8+ T cells (0.01%).
Polyfunctionality
SPICE software was used to visualize and analyze nonoverlap-
ping functional subsets [14]. The polyfunctionality index (PI)
algorithm was obtained from FunkyCells ToolBox, version
0.1.0 beta (available at: http://www.FunkyCells.com) [15]. To
calculate the PI, each subset deﬁned by a given number of dis-
played functions has a weight assigned, which is then multiplied
with the subset frequency. The PI is the sum of these products
(PI ¼Pni¼0 Fi  ði=nÞq, where Fi is the frequency of cells per-
forming i simultaneous functions, q is the polyfunctionality pa-
rameter determining the weight of the subsets, and n is the
number of possible functions). The polyfunctionality parameter
q was set to 1 as previously described [15]. Samples containing
<0.1% activated events were not included in correlations of PI
and other parameters.
Statistical Analysis
SPSS v22 software (IBM, London, United Kingdom) was used
for statistical analysis. Nonparametric (eg, Mann–Whitney)
tests were used to compare groups unless normality of the
data distribution was assumed (based on Q/Q plots and the
Kolmogorov–Smirnov test). Differences between >2 groups (in-
dependent samples) were tested with the Kruskal–Wallis test.
Differences with respect to several parameters (related samples)
were tested with Friedman analysis of variance. Where appro-
priate, T-cell frequencies were log transformed to normalize
distribution or improve visual presentation. P values of <.05
were considered signiﬁcant for single end points. Where there
were multiple end points, Bonferroni correction was applied to
adjust the signiﬁcance level from P≤ .05 to P≤ .05/n, where n is
the number of end points.
RESULTS
The Functional T-Cell Subset Distribution Is Very Similar in Young and
Older United Kingdom Participants
CMV-speciﬁc CD4+ and CD8+ T cells were analyzed in a
healthy United Kingdom cohort (2 age groups) and a cohort
of oldest old Italians. The main interest in the latter group
was to contrast ﬁndings in the older group (within the normal
life expectancy) against exceptional survivors. They were not
considered examples of normal aging.
After stimulating PBMCs with 19 representative CMV target
proteins, the 5 simultaneously measured T-cell activation read-
outs (CD107, CD154, IL-2, TNF, and IFN-γ) gave rise to 32
functional (Boolean) subsets when positive/negative populations
Table 2. Cytomegalovirus Peptide Pools Used for Stimulation
Tube Protein(s) Peptides, No.
1 UL55 224
2 UL83 138
3 UL86 340
4 UL122 120
5 UL123 143
6 UL99 45
7 UL153 67
8 UL32 260
9 UL28 92
10 UL48Aa 281
11 UL48Ba 281
12 US3 44
13 UL151 + UL82 219 (82 + 137)
14 UL94 + US29 197 (84 + 113)
15 UL103 + US32 103 (60 + 43)
16 US24 + UL36 240 (123 + 117)
a UL48 was divided into 2 pools for stimulation (UL48A and UL48B), but results were
combined.
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were gated for each marker (n = 25), but the subset negative for
all markers was discounted from the analysis, leaving 31; these
were visualized using SPICE software [14]. However, none of
the functional CD4+ or CD8+ T-cell subsets was signiﬁcantly
different between the young and older United Kingdom partic-
ipants, when analyzing UL83-speciﬁc responses (Supplementa-
ry Figure 2); this was also true for UL55-speciﬁc CD4+ T cells
and UL123-speciﬁc CD8+ T cells (data not shown). For this type
of analysis, the signiﬁcance threshold was set at a P value
of ≤ .0016 (Bonferroni multiple end point correction; 31 end
points).
To reduce the complexity of the information, we determined
the proportions of T-cell subsets with speciﬁc numbers of par-
allel functions (1 to 5; Figure 1A). These were very similar in
young and older people, except for a slightly (but signiﬁcantly)
higher proportion of UL83-speciﬁc CD4+ T cells with 2
functions observed in the older people. We also studied the
total percentage of cells expressing each activation marker, to
explore functional marker dominance (note that such subsets
overlap). However, no signiﬁcant differences were visible
(Figure). Nevertheless, the data shown in Figure 1 and Supple-
mentary Figure 2 suggest that many smaller subset differences
might exist and that the lack of statistical signiﬁcance could be
due to the small group sizes, particularly among the young. The
number of participants with a UL55-speciﬁc CD4+ T-cell re-
sponse and UL123-speciﬁc CD8+ T-cell response were only 6
of 26 and 9 or 26, respectively, among the young participants,
but these were the second and third most frequently recognized
proteins in the study. This meant it was highly unlikely that we
would be able to recruit sufﬁcient numbers of responders for
each protein to complete a representative comparison between
the age groups protein by protein. We therefore decided to base
Figure 1. The functional T-cell response composition in young and older people appears to be very similar. Peripheral blood mononuclear cells (PBMCs) from cytomegalovirus
(CMV)–positive donors were stimulated overnight with 19 CMV protein–derived overlapping peptide-pools. Activated T cells and their functional composition were analyzed by
flow cytometry, including the activation markers, degranulation (CD107), CD154, interleukin 2 (IL-2), tumor necrosis factor (TNF), and interferon γ (IFN-γ). Responses from the
United Kingdom cohort are shown for the 2 most frequently targeted proteins for each T-cell subset. A, Nonoverlapping subsets exhibiting 5, 4, 3, or 2 parallel functions or just 1
single function are shown as a proportion of the specifically activated T cells (in order of decreasing polyfunctionality). A significant difference between the age groups is
observed for UL-83–specific CD4+ T cells with 2 functions, but, on the whole, subset distributions appear to be very similar. B, The functional dominance of each activation
marker in a given response is assessed by the proportion of activated cells expressing it. Some variability between proteins was revealed, but there was no significant dif-
ferences between the age groups. There were 5 end points evaluated, with the significance threshold set at a P value of≤ .01. P values were determined by the Mann–Whitney
test with Bonferroni correction for multiple end points.
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the comparison of polyfunctionality on all present T-cell re-
sponses in the 2 age groups, irrespective of the recognized target
protein. In addition, we decided to use an algorithm that would
assign an aggregate measure of polyfunctionality to each re-
sponse, because interpreting group differences with respect to
multiple percentages of subsets with slightly different functional
characteristics appeared to be too complex. We therefore ap-
plied the recently introduced polyfunctionality index (PI) to
our data. The PI is a compound measure, which elegantly re-
duces the complexity inherent in multiple subset comparisons
to a single index number [15, 16].
The PI Is Very Similar in the Young and Older United Kingdom Groups
but Lower in the Oldest Old Survivors
We ﬁrst determined the PI for every single response and then
the average PI for CD4+ and CD8+ T-cell responses in each in-
dividual. This allowed us to include all responses to all 19 pro-
teins in our comparison. Surprisingly, the average PI appeared
to be slightly higher in the older participants, but this difference
was not statistically signiﬁcant (Figure 2A).
However, the oldest old individuals, who were considered ex-
amples of exceptionally successful aging, showed a signiﬁcantly
lower PI in their CD4+ and CD8+ T-cell responses than the
older participants (Figure 2B). When comparing the UL83-
speciﬁc T-cell response between the older and oldest old partic-
ipants in more detail, using SPICE [14], larger percentages of
functionally focused subsets (1 or 2 functions) present in the
latter were consistent with this observation (Supplementary
Figure S3). In particular, they had higher frequencies of
UL83-speciﬁc CD4+ T cells upregulating CD154 and IFN-γ or
degranulation alone. Among UL83-speciﬁc CD8+ T cells, the
subsets displaying IFN-γ alone or IFN-γ and degranulation
were signiﬁcantly increased, compared with the older group.
The subset displaying degranulation alone also seemed marked-
ly increased, but this difference did not achieve statistical signif-
icance. Concerning UL55-speciﬁc CD4+ T-cell responses, the
oldest old had higher frequencies of the subset displaying
only degranulation (mirroring the UL-83–speciﬁc response),
but there were no differences in the other subsets (data not
shown). For UL123-speciﬁc CD8+ T cells, by contrast, no signif-
icant differences were found (data not shown).
Polyfunctionality Varies Between Responses Targeting Different
Proteins but Is Related to Response Size
We also applied the PI to the comparison of protein-speciﬁc re-
sponses in the United Kingdom cohort (young and older par-
ticipants together). For this purpose, we selected the 5 most
frequently recognized CD4+ and CD8+ T-cell target proteins.
Whereas differences for CD4+ T cells were apparent but not
statistically signiﬁcant (Figure 2C, left), signiﬁcant differences
were observed for CD8+ T cells (Figure 2C, right). To elicit
how individual functional subsets reﬂected these differences
for the most frequently recognized proteins, we used SPICE
[14]. Visualization of all individual subsets suggested that
UL55-speciﬁc CD4+ T cells included signiﬁcantly larger subsets
displaying IFN-γ and TNF, or IFN-γ, TNF, and degranulation
(CD107) than UL83-speciﬁc CD4+ T cells. Meanwhile,
UL123-speciﬁc CD8+ T cells included signiﬁcantly larger sub-
sets displaying IFN-γ and TNF in combination or alone than
UL83-speciﬁc CD8+ T cells (Supplementary Figure S4). An in-
crease of subsets focused on single effector markers is consistent
with a loss of polyfunctionality.
Interestingly, there seemed to be different levels of polyfunc-
tionality for responses targeting different proteins. Of note,
these levels per se did not seem to depend on whether average
responses to a protein were large or small. For example, UL123
induced signiﬁcantly larger CD8+ T-cell responses than UL83
(Figure 2C, bottom right), but the responses to UL83 were sig-
niﬁcantly more polyfunctional (Figure 2C, top right). A similar
trend was seen for CD4+ T-cell responses to UL55 (bigger) and
UL83 (more polyfunctional), but differences were not signiﬁ-
cant. However, with respect to individual proteins, there was a
signiﬁcant association between PI and response size. This
was observed for CD4+ T-cell responses to UL83 and UL55
(Figure 2D, top), as well as for CD8+ T-cell responses to
UL83 and UL123 (Figure 2D, bottom). Similar but statistically
nonsigniﬁcant associations between response size and PI were
observed for 1 additional CD8+ T-cell and 2 additional CD4+
T-cell among the top 5 recognized proteins in each T-cell com-
partment (the numbers of cases were lower than for the 3 dom-
inant proteins mentioned above).
Finally, the differences in PI between UL83- and UL55-spe-
ciﬁc CD4+ T cells, as well as UL83- and UL123-speciﬁc CD8+ T
cells (P = .018 and P = .066, respectively; data not shown) were
preserved in the oldest old group, albeit not statistically signiﬁ-
cantly so for CD8+ T cells. An association between response size
and PI was visible in the oldest old for the same proteins as in
the United Kingdom cohort but only as a nonsigniﬁcant trend
(due to a lack of sufﬁcient numbers of observations; data not
shown).
DISCUSSION
The present study provides a comprehensive analysis of the pol-
yfunctionality of CMV-speciﬁc T cells at different ages. It covers
CD4+ and CD8+ T-cell responses to 19 different CMV target
proteins, examines healthy participants in 2 different age
groups, and also includes a cohort of successfully aged, oldest
old individuals for comparison. We analyzed 5 simultaneous
functional readouts and applied the recently introduced PI in
addition to conventional subset-by-subset analysis. Use of the
PI enabled us to analyze (aggregate) polyfunctionality in indi-
viduals and groups of individuals, responses to different pro-
teins, as well as correlations between polyfunctionality and
response size.
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Our results agree with published reports indicating that age
per se is not linked to reduced polyfunctionality of CD8+ T-cell
responses to a range of different organisms [17] or altered
CD4+ and CD8+ T-cell responses to superantigens [18]. For
statistical robustness, when comparing the PI between T-cell
responses of different protein speciﬁcities, we focused on the
most frequently recognized ones (U83, UL123, and UL55).
But when comparing the PI of CMV-speciﬁc T-cell responses
between age groups, all responses to all proteins were account-
ed for. Since for each individual, the average PI across their spe-
ciﬁc CD4+ and CD8+ T-cell responses was computed prior to
comparing these averages between the age groups, our ap-
proach provided unprecedented coverage of CMV target pro-
teins for the analysis of polyfunctionality. It convincingly
demonstrates that aging within the expected life-span in the
United Kingdom (and many other countries in the world)
has no obvious detrimental effect on the functional diversity
of CMV-speciﬁc T cells.
With respect to what determines T-cell polyfunctionality, it is
interesting that responses to different target proteins had differ-
ent PIs. This might be explained by the presentation of different
CMV proteins by antigen-presenting cells in different contexts
Figure 2. The polyfunctionality index of cytomegalovirus (CMV)–specific T-cell responses varies between protein targets and is reduced in the oldest old group. The poly-
functionality index (PI) captures functional subset distributions by weighting the number of functions, as well as subset size [15, 16]. For the present study, a linear relationship
between the number of functions and the relative weight of a subset was selected (eg, subsets with 2 functions were assigned twice the weight of subsets with 1 function and
subsets with 3 functions were assigned 3 times the weight of subsets with 1 function). A, In each individual, the PI was calculated for all positive responses and averaged. Dot
plots show the distribution of the average PI in young and older United Kingdom individuals for CD4+ and CD8+ T cells. No significant differences between the groups were
observed. B, The comparison of the average PI between the older and the oldest old groups reveals significantly reduced polyfunctionality in the latter. C, The PI of CD4+ and
CD8+ T-cell responses is shown by target protein for the 5 most frequently recognized proteins in each T-cell compartment (each protein was recognized by ≥10 donors; only
young and older United Kingdom donors were included in this analysis). Differences apparent for CD4+ T cells were not statistically significant (by the Kruskal–Wallis Test), but
the data suggest that responses to UL83 were the most polyfunctional (upper left). However, significant differences are revealed for CD8+ T cells (upper right). Responses to
UL83 showed the highest and responses to UL32 the lowest polyfunctionality. Lower panels show T-cell response size for each target protein (CD4+ T cells on the left and CD8+
T cells on the right), and box plots show medians, interquartile ranges, and outliers (o). D, Interestingly, with respect to each analyzed protein, the PI significantly correlated with
response size in a linear fashion. Correlations were moderate to strong. The strongest correlation was found for CD4+ T-cell responses to UL83 (only United Kingdom donors
were included in this analysis). Abbreviation: NS, not significant.
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[19] and/or the efﬁciency of antigen presentation, including
T-cell receptor antigen sensitivity and the amount of antigen
available [20]. It is conceivable that the same protein might elicit
responses of different polyfunctionality (and magnitude) in co-
horts of different genetic background (ie, certain HLA-types
might contribute to the presentation of peptides that are recog-
nized with higher T-cell receptor afﬁnity and avidity than oth-
ers) [21]. These aspects clearly warrant further study.
In addition, a striking and signiﬁcant association between the
PI and CD4+ and/or CD8+ T-cell response size was observed for
responses to UL83, UL123, and UL55 in the young and older
donors. It remains unclear whether this holds generally true
for subdominant proteins. In the oldest old we saw the same
trend that polyfunctionality increased with response size, but
there were not enough cases for correlations to reach statistical
signiﬁcance.
The present study signiﬁcantly extends recent work in a large
group of (exclusively) older people with respect to UL83-speciﬁc
T-cell responses [8]. That study showed a correlation between
the increase of certain polyfunctional subsets (eg, exhibiting
TNF, IFN-γ, and perforin expression, as well as degranulation)
and the size of the UL83-speciﬁc T-cell response. However, un-
like in the present study, T-cell polyfunctionality was not as-
sessed by an aggregate measure such as the PI, and other
proteins were not included. Also, a comparison between older
and oldest old individuals was not made.
Perhaps unexpectedly, results in the oldest old group demon-
strated decreased polyfunctionality, with an overall reduced PI
of both CD4+ and CD8+ T-cell responses. In agreement with
this, our detailed subset analysis indicated that several subsets
with just 1 or 2 of the measured functions were increased (eg,
CD8+ T cells displaying IFN-γ alone or IFN-γ and degranula-
tion). Studies conducted over a decade ago suggested that, in
very old people, the expansion of UL83-speciﬁc T cells (recog-
nizing speciﬁc epitopes in a narrow HLA context) was linked to
functional exhaustion [22,23]. The individuals examined in that
work were similar in age to our oldest old group, and the de-
crease in polyfunctionality we have measured in this group
might be a correlate of the functional exhaustion reported in
these earlier studies, which used fewer activation markers.
In any case, it seems to go against the notion that higher pol-
yfunctionality is associated with better protection if it is reduced
in oldest old persons [15]. Protection from CMV disease (prob-
ably the most important role of CMV-speciﬁc T cells) might
well be provided by a very small number of CMV-speciﬁc
cells [10], but decreased polyfunctionality of large responses
in very old people might reduce CMV-associated immune pa-
thology. Such may include, for example, vascular pathology
contributing to cardiovascular events and stroke, which are
major causes of death in older people [12, 24–27]. It is impor-
tant to remember in this context that cells with greater
polyfunctionality also produce larger and potentially more
harmful quantities of effector cytokines [9]. A link between
CMV-speciﬁc T-cell polyfunctionality and increased immune
pathology would undermine the idea that T-cell polyfunction-
ality at older ages is necessarily a good thing. It might be of ad-
vantage for long-term survival, by contrast, if the level of
pathogen control is balanced against the risk of collateral tissue
damage. Maybe this is achieved to an extent by reduced poly-
functionality of CMV-speciﬁc T-cell responses in very old peo-
ple. This is an important question to be answered, in light of the
growing interest in the possible role of CMV in a range of age-
associated pathologies [28–30].
In conclusion, our study has revealed new aspects of CMV-
speciﬁc T-cell polyfunctionality, in particular the previously un-
known effects of target protein speciﬁcity and response size.
While we now have a better understanding of this complex
issue, the discovery that T-cell polyfunctionality in the oldest
old long-term survivors is actually reduced has raised the ques-
tion of whether increased T-cell polyfunctionality in older peo-
ple could potentially limit survival.
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